Similar to our study, Mustea et al. [44] demonstrated that ovarian cancer patients, especially those with serous tumors, present with elevated peritoneal fluid concentrations of IL-10, markedly higher than serum levels of this cytokine. This evidence concerns the gene IL10 and ovarian carcinoma.